Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks: does management convey that deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago, so that each new instance of essentially the same business is worth more to the company than the last? We need to look for evidence in the transcript. The transcript is about WEC Energy Group's Q1 2024 earnings call. They discuss capital plan, projects, investments, etc. Key points: They mention Delilah I Solar Energy, Samson Solar, Maple Flats Solar. They are investing additional $560 million in Infrastructure segment. They mention reallocating $800 million from Illinois operations. They talk about rate cases, generation projects, etc. But the question is specifically about successive engagements of the same kind coming in at progressively larger size. For example, are they signing bigger solar projects now than before? Or bigger data center deals? Or bigger contracts? In the transcript, they talk about Microsoft data center complex. They mention that Microsoft is building a massive data center complex, and they are the supplier for all energy. They also mention that Microsoft has acquired additional acreage, and they are in discussions for further expansion. But is that an escalation in size? They say: "Microsoft has now acquired substantial additional acreage. In fact, they control 1,345 acres now in that technology park." And they are in weekly discussions. But is that a comparison to their own past? They don't explicitly say that the size of the data center deals is escalating compared to before. They mention that they added 1,400 megawatts of dispatchable capacity to the plan to meet demand. But that's about capacity, not necessarily about individual deals being larger. They also talk about new generation projects: 1,100 MW combustion turbines, 128 MW RICE units, etc. But these are new projects, not necessarily successive engagements of the same kind with escalating size. The question is about "successive engagements of the same kind" - meaning the company's own repeatable business.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.